Assessment of risk factors associated with multi-drug resistant tuberculosis (MDR-TB) in Gulu regional referral hospital

被引:2
|
作者
Omona, Kizito [1 ]
Opiyo, Albert Mucha [2 ]
机构
[1] Uganda Martyrs Univ, Fac Hlth Sci, Kampala, Uganda
[2] Victory Hlth Serv, Dept Publ Hlth, Gulu City, Uganda
关键词
MDR-TB; tuberculosis; HIV; Gulu Regional Referral Hospital; EPIDEMIOLOGY;
D O I
10.4314/ahs.v23i3.41
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Multi-drug resistant tuberculosis (MDR-TB) is increasingly recognized as emerging infectious disease of public health concern. Globally, 206030 people were diagnosed with MDR-TB in 2019, representing a 10% increase from 186883peo-ple who had it in 2018. In Uganda, the prevalence of MDR among new TB cases is 4.4% and 17.7% among previously treated TB cases.Aim: To determine the risk factors associated with MDR-TB among tuberculosis patients in Gulu regional referral hospital.Material and Methods: A cross-sectional analytical study using both quantitative and qualitative methods of data collection and analysis was used. Data was collected from 384 TB patients using data extraction form and 6 Key informant interviews conducted. Analysis using Pearson chi-square test was run.Results: HIV positive patients were 2.6 times more likely to be infected with MDR-TB than HIV negative patients [AOR=2.6: 95% CI 1.34- 5.85: P=0.006]. Previously treated TB patients were 2.8 times more likely to be infected with MDR-TB than newly diagnosed TB patients [AOR=2.8: 95% CI 1.33- 5.85: P=0.006]. Defaulting TB patients were 3.1 times more likely to be infected with MDR-TB than the non-defaulting TB patients [AOR=3.1]Conclusion: There is high prevalence of drug resistance among patients attending TB treatment at the facility.
引用
收藏
页码:343 / 357
页数:15
相关论文
共 50 条
  • [21] Current and developing therapies for the treatment of multi drug resistant tuberculosis (MDR-TB) in India
    Muniyandi, Malaisamy
    Ramachandran, Rajeswari
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (13) : 1301 - 1309
  • [22] Analysis of multi drug resistant tuberculosis (MDR-TB) financial protection policy: MDR-TB health insurance schemes, in Chhattisgarh state, India
    Kundu, Debashish
    Sharma, Nandini
    Chadha, Sarabjit
    Laokri, Samia
    Awungafac, George
    Jiang, Lai
    Asaria, Miqdad
    HEALTH ECONOMICS REVIEW, 2018, 8
  • [23] Analysis of multi drug resistant tuberculosis (MDR-TB) financial protection policy: MDR-TB health insurance schemes, in Chhattisgarh state, India
    Debashish Kundu
    Nandini Sharma
    Sarabjit Chadha
    Samia Laokri
    George Awungafac
    Lai Jiang
    Miqdad Asaria
    Health Economics Review, 8
  • [24] MULTIPLE-DRUG RESISTANT TUBERCULOSIS (MDR-TB) - HIV-INFECTION AND OTHER RISK-FACTORS
    KEYES, C
    KULPA, B
    FOX, K
    MULLER, M
    WOODARD, P
    DIFERINANDO, G
    FEDER, H
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A487 - A487
  • [25] Impact of COVID-19 on Multi-drug Resistant Tuberculosis (MDR-TB) Registrations and Outcomes in Pakistan: The Challenging Journey Continues
    Imran, M. D.
    Iqbal, Z.
    Uddin, A.
    Javaid, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [26] Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran
    Mirsaeidi, SM
    Tabarsi, P
    Khoshnood, K
    Pooramiri, MV
    Rowhani-Rahbar, A
    Mansoori, SD
    Masjedi, H
    Zahirifard, S
    Mohammadi, F
    Farnia, P
    Masjedi, MR
    Velayati, AA
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2005, 9 (06) : 317 - 322
  • [27] Prevalence and Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) among Presumptive MDR-TB Patients in Tigray Region, Northern Ethiopia
    Mehari, Kibriti
    Asmelash, Tsehaye
    Hailekiros, Haftamu
    Wubayehu, Tewolde
    Godefay, Hagos
    Araya, Tadele
    Saravanan, Muthupandian
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2019, 2019
  • [28] FACTORS ASSOCIATED WITH MULTI-DRUG RESISTANT TUBERCULOSIS IN BANGLADESH
    Flora, M. S.
    Amin, M. Nurul
    Karim, M. R.
    Afroze, S.
    Islam, S.
    Alam, M. Ashraful
    Hossain, M. Motahar
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2011, 65 : A332 - A332
  • [29] Molecular modeling and in silico characterization of mutations associated with multiple drug resistant tuberculosis (MDR-TB) and extensive drug resistant tuberculosis (XDR-TB)
    Joginipelli, Sravanthi
    Darsey, Jerry A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [30] Risk factors of mortality in patients with multi-drug resistant TB
    Molalign, Solomon
    Wencheko, Eshetu
    ETHIOPIAN JOURNAL OF HEALTH DEVELOPMENT, 2015, 29 (02) : 82 - 89